Ubs Asset Management Americas Inc 89bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 268,798 shares of ETNB stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
268,798
Previous 178,691
50.43%
Holding current value
$2.59 Million
Previous $1.37 Million
42.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ETNB
# of Institutions
208Shares Held
158MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$197 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$191 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$138 Million4.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$89.6 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$68.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $447M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...